On May 8, 2014, MeetMe, Inc. (NASDAQ:MEET) issued a press release announcing its financial results for the quarter ended March 31, 2014. MeetMe Inc. (NASDAQ:MEET) net profit margin is -27.00% and weekly performance is -25.65%. On last trading day company shares ended up $2.29. Analysts mean target price for the company is $5.00. MeetMe Inc. (NASDAQ:MEET) distance from 50-day simple moving average (SMA50) is -26.80%.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) sued US regulators, seeking to block approval of a generic version of its multiple-sclerosis drug Copaxone, a product that accounts for more than half the company’s revenue and is set to go off patent on 24 May. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares advanced 1.50% in last trading session and ended the day on $49.99. TEVA gross Margin is 53.00% and its return on assets is 2.90%.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) quarterly performance is 14.34%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on May 7 reported financial results for the first quarter of 2014, including revenue from sales of Iclusig (ponatinib) and licensing agreements. The Company also provided an update on corporate developments. Total revenue for the quarter ended March 31, 2014 was $11.8 million, which includes product revenue from sales of Iclusig and license revenue. Net loss for the quarter ended March 31, 2014 was $49.8 million, or $0.27 per share, compared to net loss of $64.7 million, or $0.36 per share, for the same period in 2013. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares moved up 2.10% in last trading session and was closed at $6.81, while trading in range of $6.54 – $6.85. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) year to date (YTD) performance is -0.15%.
Novartis AG (ADR) (NYSE:NVS) on 5 may presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control. Novartis AG (ADR) (NYSE:NVS) ended the last trading day at $88.61. Company weekly volatility is calculated as 0.68% and price to cash ratio as 31.36.Novartis AG (ADR) (NYSE:NVS) showed a positive weekly performance of 0.96%.
FBR Capital Markets upgraded shares of HomeAway (NASDAQ:AWAY) from a market perform rating to an outperform rating in a research report sent to investors on Thursday morning, American Banking News reports. The firm currently has $45.00 price target on the stock, up from their previous price target of $34.00. HomeAway, Inc. (NASDAQ:AWAY) net profit margin is 4.60% and weekly performance is -3.31%. On last trading day company shares ended up $32.12. Analysts mean target price for the company is $44.38. HomeAway, Inc. (NASDAQ:AWAY) distance from 50-day simple moving average (SMA50) is -15.61%.
Leave a Reply